Species | Faecalibacillus faecis | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Lineage | Bacteria; Firmicutes; Bacilli; Erysipelotrichales; Erysipelatoclostridiaceae; Faecalibacillus; Faecalibacillus faecis | |||||||||||
CAZyme ID | MGYG000002444_01340 | |||||||||||
CAZy Family | GH84 | |||||||||||
CAZyme Description | hypothetical protein | |||||||||||
CAZyme Property |
|
|||||||||||
Genome Property |
|
|||||||||||
Gene Location | Start: 69301; End: 74946 Strand: + |
Family | Start | End | Evalue | family coverage |
---|---|---|---|---|
GH84 | 182 | 485 | 4.3e-101 | 0.9932203389830508 |
Cdd ID | Domain | E-Value | qStart | qEnd | sStart | sEnd | Domain Description |
---|---|---|---|---|---|---|---|
pfam07555 | NAGidase | 7.80e-114 | 182 | 484 | 1 | 293 | beta-N-acetylglucosaminidase. This family has previously been described as a hyaluronidase. However, more recently it has been shown that this family has beta-N-acetylglucosaminidase activity. |
pfam02838 | Glyco_hydro_20b | 2.41e-24 | 34 | 175 | 1 | 123 | Glycosyl hydrolase family 20, domain 2. This domain has a zincin-like fold. |
cd00057 | FA58C | 1.54e-09 | 974 | 1048 | 47 | 128 | Substituted updates: Jan 31, 2002 |
pfam00754 | F5_F8_type_C | 2.10e-08 | 945 | 1047 | 11 | 111 | F5/8 type C domain. This domain is also known as the discoidin (DS) domain family. |
pfam00754 | F5_F8_type_C | 4.91e-08 | 1211 | 1332 | 16 | 117 | F5/8 type C domain. This domain is also known as the discoidin (DS) domain family. |
Hit ID | E-Value | Query Start | Query End | Hit Start | Hit End |
---|---|---|---|---|---|
BCL58377.1 | 0.0 | 1 | 1880 | 1 | 1875 |
QMW73896.1 | 0.0 | 2 | 1876 | 19 | 1890 |
QPS12837.1 | 0.0 | 2 | 1876 | 19 | 1890 |
QQY28346.1 | 0.0 | 2 | 1876 | 19 | 1890 |
QQV04685.1 | 0.0 | 2 | 1876 | 19 | 1890 |
Hit ID | E-Value | Query Start | Query End | Hit Start | Hit End | Description |
---|---|---|---|---|---|---|
6PV4_A | 4.50e-231 | 32 | 646 | 29 | 653 | Structureof CpGH84A [Clostridium perfringens ATCC 13124],6PV4_B Structure of CpGH84A [Clostridium perfringens ATCC 13124],6PV4_C Structure of CpGH84A [Clostridium perfringens ATCC 13124],6PV4_D Structure of CpGH84A [Clostridium perfringens ATCC 13124] |
6PWI_A | 3.31e-115 | 34 | 639 | 33 | 626 | Structureof CpGH84D [Clostridium perfringens ATCC 13124],6PWI_B Structure of CpGH84D [Clostridium perfringens ATCC 13124] |
2CBI_A | 7.99e-49 | 39 | 556 | 18 | 520 | Structureof the Clostridium perfringens NagJ family 84 glycoside hydrolase, a homologue of human O-GlcNAcase [Clostridium perfringens],2CBI_B Structure of the Clostridium perfringens NagJ family 84 glycoside hydrolase, a homologue of human O-GlcNAcase [Clostridium perfringens],2CBJ_A Structure of the Clostridium perfringens NagJ family 84 glycoside hydrolase, a homologue of human O-GlcNAcase in complex with PUGNAc [Clostridium perfringens],2CBJ_B Structure of the Clostridium perfringens NagJ family 84 glycoside hydrolase, a homologue of human O-GlcNAcase in complex with PUGNAc [Clostridium perfringens],2V5C_A Family 84 glycoside hydrolase from Clostridium perfringens, 2.1 Angstrom structure [Clostridium perfringens],2V5C_B Family 84 glycoside hydrolase from Clostridium perfringens, 2.1 Angstrom structure [Clostridium perfringens],2VUR_A Chemical dissection of the link between Streptozotocin, O-GlcNAc and pancreatic cell death [Clostridium perfringens],2VUR_B Chemical dissection of the link between Streptozotocin, O-GlcNAc and pancreatic cell death [Clostridium perfringens],2X0Y_A Screening-based discovery of drug-like O-GlcNAcase inhibitor scaffolds [Clostridium perfringens],2X0Y_B Screening-based discovery of drug-like O-GlcNAcase inhibitor scaffolds [Clostridium perfringens] |
5OXD_A | 1.00e-48 | 39 | 556 | 20 | 522 | Complexof a C. perfringens O-GlcNAcase with a fragment hit [Clostridium perfringens] |
2J62_A | 1.07e-48 | 39 | 556 | 18 | 520 | Structureof a bacterial O-glcnacase in complex with glcnacstatin [Clostridium perfringens],2J62_B Structure of a bacterial O-glcnacase in complex with glcnacstatin [Clostridium perfringens],2WB5_A GlcNAcstatins are nanomolar inhibitors of human O-GlcNAcase inducing cellular hyper-O-GlcNAcylation [Clostridium perfringens],2WB5_B GlcNAcstatins are nanomolar inhibitors of human O-GlcNAcase inducing cellular hyper-O-GlcNAcylation [Clostridium perfringens] |
Hit ID | E-Value | Query Start | Query End | Hit Start | Hit End | Description |
---|---|---|---|---|---|---|
P26831 | 0.0 | 1 | 1605 | 1 | 1480 | Hyaluronoglucosaminidase OS=Clostridium perfringens (strain 13 / Type A) OX=195102 GN=nagH PE=1 SV=2 |
Q8XL08 | 3.57e-47 | 39 | 556 | 48 | 550 | O-GlcNAcase NagJ OS=Clostridium perfringens (strain 13 / Type A) OX=195102 GN=nagJ PE=1 SV=1 |
Q0TR53 | 2.51e-46 | 39 | 556 | 48 | 550 | O-GlcNAcase NagJ OS=Clostridium perfringens (strain ATCC 13124 / DSM 756 / JCM 1290 / NCIMB 6125 / NCTC 8237 / Type A) OX=195103 GN=nagJ PE=1 SV=1 |
Q89ZI2 | 4.59e-45 | 125 | 785 | 97 | 737 | O-GlcNAcase BT_4395 OS=Bacteroides thetaiotaomicron (strain ATCC 29148 / DSM 2079 / JCM 5827 / CCUG 10774 / NCTC 10582 / VPI-5482 / E50) OX=226186 GN=BT_4395 PE=1 SV=1 |
O60502 | 4.30e-19 | 183 | 439 | 63 | 325 | Protein O-GlcNAcase OS=Homo sapiens OX=9606 GN=OGA PE=1 SV=2 |
Other | SP_Sec_SPI | LIPO_Sec_SPII | TAT_Tat_SPI | TATLIP_Sec_SPII | PILIN_Sec_SPIII |
---|---|---|---|---|---|
0.000676 | 0.370103 | 0.628446 | 0.000282 | 0.000269 | 0.000204 |
Copyright 2022 © YIN LAB, UNL. All rights reserved. Designed by Jinfang Zheng and Boyang Hu. Maintained by Yanbin Yin.